The vaccine development process by Bharat Biotech, Biological E Ltd and Aurobindo Pharma are currently in various stages, while Dr Reddy's and Hetero have tie ups for manufacturing.
Official sources said the visit of the foreign heads of missions in India to Hyderabad is being organised as part of MEA's COVID-19 briefing initiative.
This is the fifth potential Covid-19 vaccine permitted for clinical trial in India, days after Dr Reddy’s Laboratories. received a go-ahead to carry out phase 2 and 3 trials in the country.
As part of the said agreement, J&J will be transferring the manufacturing technology to Biological E. Johnson & Johnson’s vaccine (Ad26.COV2) is currently in the Phase 1/2a of clinical trials
Pharma companies demanded a branch of Central Drugs Standard Control Organisation at Hyderabad for South India.
Leading vaccine major Serum Institute of India has said that it is hoping to develop a COVID-19 vaccine by the year-end.